{"id":3093712,"date":"2024-02-02T17:38:18","date_gmt":"2024-02-02T22:38:18","guid":{"rendered":"https:\/\/wordpress-1016567-4521551.cloudwaysapps.com\/plato-data\/zyus-strengthens-expertise-of-clinical-advisory-committee-with-the-appointment-of-dr-hance-clarke-medical-marijuana-program-connection\/"},"modified":"2024-02-02T17:38:18","modified_gmt":"2024-02-02T22:38:18","slug":"zyus-strengthens-expertise-of-clinical-advisory-committee-with-the-appointment-of-dr-hance-clarke-medical-marijuana-program-connection","status":"publish","type":"station","link":"https:\/\/platodata.io\/plato-data\/zyus-strengthens-expertise-of-clinical-advisory-committee-with-the-appointment-of-dr-hance-clarke-medical-marijuana-program-connection\/","title":{"rendered":"ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke – Medical Marijuana Program Connection"},"content":{"rendered":"


SASKATOON, Saskatchewan\u2013(BUSINESS WIRE)\u2013 #HealthcareInnovations\u2013ZYUS Life Sciences Corporation (the \u201cCompany\u201d) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced the appointment of Hance Clarke, MD, PhD, FRCPC to ZYUS Life Sciences Inc.\u2019s Clinical Advisory Committee. Dr. Clarke\u2019s extensive background in healthcare and pain management aligns seamlessly with the committee\u2019s mission to pro<\/p>\n

Source link <\/a><\/p>\n